Zoledronate-pulsed dendritic cell-based anticancer vaccines

Por Kamigaki, Takashi, Takahara, Masashi, Maekawa, Ryuji, Goto, Shigenori
Publicado em 2013

Improved in vivo Antitumor Efficacy and Reduced Systemic Toxicity of Carboxymethylpullulan‐peptide‐doxorubicin Conjugates

Por Nogusa, Hideo, Hamana, Hiroshi, Uchida, Naomi, Maekawa, Ryuji, Yoshioka, Takayuki
Publicado no Jpn J Cancer Res (2000)

Large-scale expansion of γδ T cells and peptide-specific cytotoxic T cells using zoledronate for adoptive immunotherapy

Por YOSHIKAWA, TOSHIAKI, TAKAHARA, MASASHI, TOMIYAMA, MAI, NIEDA, MIE, MAEKAWA, RYUJI, NAKATSURA, TETSUYA
Publicado em 2014

Preclinical in vivo Antitumor Efficacy of Nedaplatin with Gemcitabine against Human Lung Cancer

Por Matsumoto, Mitsunobu, Takeda, Yukihiro, Maki, Hideo, Hojo, Kanji, Wada, Tohru, Nishitani, Yoshinori, Maekawa, Ryuji, Yoshioka, Takayuki
Publicado no Jpn J Cancer Res (2001)

Possibility of γδ T cell immunotherapy for HTLV-1-infected individuals

Por Sato, Tomoo, Muto, Masato, Araya, Natsumi, Maekawa, Ryuji, Suzuki, Noboru, Utsunomiya, Atae, Seino, Ken-ichiro, Yamano, Yoshihisa
Publicado em 2011

Combination Chemotherapy with Nedaplatin and Cyclophosphamide in Human Ovarian Cancer Model

Por Uchida, Naomi, Yoshida, Hiroshi, Yamada, Hajime, Wada, Tohru, Daikatsu, Kouji, Ikeuchi, Isao, Maekawa, Ryuji, Sugita, Kenji, Yoshioka, Takayuki
Publicado no Jpn J Cancer Res (1999)